Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Relationship between resistin and aPAI-1 levels with insulin resistance in Saudi children.

Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Draz HM.

Pediatr Int. 2010 Aug;52(4):551-6. doi: 10.1111/j.1442-200X.2010.03091.x.

PMID:
20113417
2.

[Serum resistin concentration and insulin resistance in obese children].

Liu GL, Fu XH, Jiang LH, Ma XC, Yang JY.

Zhonghua Er Ke Za Zhi. 2006 Feb;44(2):114-7. Chinese.

PMID:
16624027
3.

Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents.

Li M, Fisette A, Zhao XY, Deng JY, Mi J, Cianflone K.

Int J Obes (Lond). 2009 Apr;33(4):424-39. doi: 10.1038/ijo.2009.44. Epub 2009 Mar 17.

PMID:
19290012
4.

Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.

Al-Harithy RN, Al-Ghamdi S.

Ann Saudi Med. 2005 Jul-Aug;25(4):283-7.

PMID:
16212119
5.

Insulin resistance is associated with at least threefold increased risk for prothrombotic state in severely obese youngsters.

Galli-Tsinopoulou A, Kyrgios I, Maggana I, Giannopoulou EZ, Kotanidou EP, Stylianou C, Papadakis E, Korantzis I, Varlamis G.

Eur J Pediatr. 2011 Jul;170(7):879-86. doi: 10.1007/s00431-010-1370-9. Epub 2010 Dec 8.

PMID:
21140274
6.

Association of serum resistin levels with metabolic syndrome and early atherosclerosis in obese Chinese children.

Chen XY, Zhang JH, Liu F, Liu HM, Song YY, Liu YL.

J Pediatr Endocrinol Metab. 2013;26(9-10):855-60. doi: 10.1515/jpem-2012-0326.

PMID:
23729554
7.

Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome.

Bahia L, Aguiar LG, Villela N, Bottino D, Godoy-Matos AF, Geloneze B, Tambascia M, Bouskela E.

Clinics (Sao Paulo). 2006 Oct;61(5):433-40.

8.

Resistin concentrations before and after weight loss in obese children.

Reinehr T, Roth CL, Menke T, Andler W.

Int J Obes (Lond). 2006 Feb;30(2):297-301.

PMID:
16189500
9.

Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans.

Utzschneider KM, Carr DB, Tong J, Wallace TM, Hull RL, Zraika S, Xiao Q, Mistry JS, Retzlaff BM, Knopp RH, Kahn SE.

Diabetologia. 2005 Nov;48(11):2330-3. Epub 2005 Sep 6.

PMID:
16143861
10.

Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism.

Koebnick C, Wagner K, Garcia AL, Gruendel S, Lahmann PH, Weickert MO, Möhlig M, Harsch IA, Einig C, Speth M, Katz N, Trippo U, Zunft HJ.

Int J Obes (Lond). 2006 Jul;30(7):1097-103. Epub 2006 Feb 14.

PMID:
16477272
11.

[Adipocytokines concentration and metabolic parameters in obese children].

Chrzanowska J, Zubkiewicz-Kucharska A, Noczyńska A.

Pediatr Endocrinol Diabetes Metab. 2011;17(3):145-51. Polish.

PMID:
22027068
12.

RELATIONSHIP OF SERUM RESISTIN WITH INSULIN RESISTANCE AND OBESITY.

Zaidi SI, Shirwany TA.

J Ayub Med Coll Abbottabad. 2015 Jul-Sep;27(3):552-5.

PMID:
26721005
13.

Relationship between changes in plasma leptin concentrations and plasminogen activator inhibitor-1 in obese prepubertal children after nine months of treatment.

Valle Jiménez M, Martos R, Morales RM, Valle R, Cañete MD, Urbano MM, Bermudo F, Cañete R.

Ann Nutr Metab. 2013;63(3):216-22. doi: 10.1159/000351597. Epub 2013 Oct 15.

PMID:
24135306
14.

Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index.

Bajnok L, Seres I, Varga Z, Jeges S, Peti A, Karanyi Z, Juhasz A, Csongradi E, Mezosi E, Nagy EV, Paragh G.

Exp Clin Endocrinol Diabetes. 2008 Nov;116(10):592-9. doi: 10.1055/s-2008-1065350. Epub 2008 May 9.

PMID:
18465683
15.

Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan.

Wu DM, Chu NF, Shen MH, Wang SC.

Clin Biochem. 2006 Aug;39(8):810-5. Epub 2006 May 26.

PMID:
16814764
16.

Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese.

Qi Q, Wang J, Li H, Yu Z, Ye X, Hu FB, Franco OH, Pan A, Liu Y, Lin X.

Eur J Endocrinol. 2008 Nov;159(5):585-93. doi: 10.1530/EJE-08-0427. Epub 2008 Aug 27.

17.

[Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].

Zhang XJ, Wang Z, Li HH, Yu L, Gao S.

Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Dec;31(12):1393-6. Chinese.

PMID:
21223671
18.

Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?

Alokail MS, Al-Daghri N, Abdulkareem A, Draz HM, Yakout SM, Alnaami AM, Sabico S, Alenad AM, Chrousos GP.

BMC Cancer. 2013 Feb 4;13:54. doi: 10.1186/1471-2407-13-54.

19.

Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance.

Janowska J, Zahorska-Markiewicz B, Olszanecka-Glinianowicz M.

Metabolism. 2006 Nov;55(11):1495-9.

PMID:
17046552
20.

Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.

Mertens I, Ballaux D, Funahashi T, Matsuzawa Y, Van der Planken M, Verrijken A, Ruige JB, Van Gaal LF.

Thromb Haemost. 2005 Dec;94(6):1190-5.

PMID:
16411393

Supplemental Content

Support Center